A Long-term Study of KT-621 Administered Orally to Participants With Asthma Previously Enrolled in a KT-621 Asthma Study

Clinical trial NCT07677059 · RECRUITING

Trial details

NCT number: NCT07677059
Sponsor: Kymera Therapeutics, Inc.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Asthma (Diagnosis)

Start date: 2026-07-01
Primary completion: 2028-12-01
Enrollment: 264

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.